Global Novel Drug Delivery Systems Overview
The novel drug delivery system is the controlled release of the drugs which is selective targeting of drugs to the site of action. Novel drug delivery system is the try to make ideal drugs. NDDS transport the drugs intact to the site of action avoiding the non-diseased tissue. NDDS is stable and delivery can be maintained under the various physiological variables. Drug delivery refers to approaches, formulations, manufacturing techniques, storage systems, and technologies involved in transporting a pharmaceutical compound to its target site to realize a desired therapeutic effect. Principles associated with drug preparation, route of administration, site-specific targeting, metabolism, and toxicity are wont to optimize efficacy and safety, and to enhance patient convenience and compliance. Drug delivery is aimed toward altering a drug's pharmacokinetics and specificity by formulating it with different excipients, drug carriers, and medical devices. There’s additional emphasis on increasing the bioavailability and duration of action of a drug to enhance therapeutic outcomes. Some research has also been focused on improving safety for the person administering the medication. For instance , several sorts of microneedle patches are developed for administering vaccines and other medications to scale back the danger of needlestick injury. The Global Novel Drug Delivery Systems Market accounted for US$ 23.05 billion in 2020 and is estimated to be US$ 29.39 billion by 2030 and is anticipated to register a CAGR of 2.50%.
Global Novel Drug Delivery Systems Dynamics
Requirement of controlled release of drugs
The requirement of controlled release of drugs because most of the drugs have an optimum range of concentration in the body which is the major driving factor for the growth of the global market. Additionally, technological advancements promoting the development of novel drugs delivery systems which is another propelling factor for the growth of the target market. For instance, in October 2017, the team of researchers at the IISC (Indian Institute of Science), India, designed a novel chemical compound which can be tailored to release aspirin inside the body, during the desired duration.
Strict government regulatory guidelines
However, stringent the government regulatory guidelines associate with developing novel drug delivery systems which is the major restraining factor for the growth of the target market. Nevertheless, the advancement in the drug delivery systems and increasing investment in the R&D for development of NDDS can create an opportunity for the global market.
Global Novel Drug Delivery Systems Segmentation
The global novel drug delivery systems market is segmented based on the product, mechanism, route of administration, mode of NDDS, and region.
Based on the route of administration, the global market is classified into oral drug delivery systems, injectable drug delivery systems, pulmonary drug delivery systems, transdermal drug delivery systems, and other routes of administration. Based on the mode of NDDS, the target market is bifurcated into targeted drug delivery systems, controlled drug delivery systems, and modulated drug delivery systems.
Regional Insights:
Based on the region the global novel drug delivery systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global novel drug delivery systems market due to increasing inclination towards the self- administration of drugs and rise in innovation in injectable drug delivery systems.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Form: Extrinsic and Intrinsic By Material Type: Concrete, Coatings, Polymers, Asphalt, Fiber-reinforced Composite, Ceramic, and Metals By End-User Industry: Energy generation, Building and Construction, Automotive and Transportation, Electronics and Semiconductors, and Medical (Implants and devices) |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Novel Drug Delivery Systems Market, By Region:
-
-
- North America
- North America Novel Drug Delivery Systems Market, By Route of Administration
- North America Novel Drug Delivery Systems Market, By Mode of NDDS
- North America Novel Drug Delivery Systems Market, By Country
- The U.S.
- Canada
- Europe
- Europe Novel Drug Delivery Systems Market, By Route of Administration
- Europe Novel Drug Delivery Systems Market, By Mode of NDDS
- Europe Novel Drug Delivery Systems Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Novel Drug Delivery Systems Market, By Route of Administration
- Asia Pacific Novel Drug Delivery Systems Market, By Mode of NDDS
- Asia Pacific Novel Drug Delivery Systems Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Novel Drug Delivery Systems Market, By Route of Administration
- Latin America Novel Drug Delivery Systems Market, By Mode of NDDS
- Latin America Novel Drug Delivery Systems Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Novel Drug Delivery Systems Market, By Route of Administration
- Middle East & Africa Novel Drug Delivery Systems Market, By Mode of NDDS
- Middle East & Africa Novel Drug Delivery Systems Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
-
Global Novel Drug Delivery Systems Key Players
The key players operating the global novel drug delivery systems market involves Abbott Laboratories, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Roche Holding AG, and Sanofi SA. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, Abbott acquired Alere Inc. (Alere), a diagnostic device and service provider to strengthen the company's presence in the diagnostics markets.
Global Novel Drug Delivery Systems Company Profile
-
-
- Abbott Laboratories
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- AstraZeneca PLC
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Bayer AG
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- GlaxoSmithKline PLC
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Johnson & Johnson
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Merck & Co. Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Novartis AG
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Pfizer Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Roche Holding AG
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Sanofi SA
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
-
- Abbott Laboratories
-
Global Novel Drug Delivery Systems Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Surgical Stapler Strategies
- Key Questions this Study will Answer
- Market Snippet, By Route of Administration
- Market Snippet, By Mode of NDDS
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Surgical Stapler Market, By Route of Administration, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Oral Drug Delivery Systems
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Injectable Drug Delivery Systems
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Pulmonary Drugs Delivery Systems
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Transdermal Drug Delivery System
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Other Routes of Administration
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Surgical Stapler Market, By Mode of NDDS, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Targeted Drug Delivery Systems
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Controlled Drug Delivery Systems
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Modulated Drug Delivery System
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Surgical Stapler Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mechanism, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Usability, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of NDDS, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of NDDS, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of NDDS, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Mode of NDDS, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
- AstraZeneca PLC
- Bayer AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Roche Holding AG
- Sanofi SA
- Abbott Laboratories
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global novel drug delivery systems market is segmented based on the product, mechanism, route of administration, mode of NDDS, and region.
The requirement of controlled release of drugs because most of the drugs have an optimum range of concentration in the body which is the major driving factor for the growth of the global market.
North America region dominates the Global Novel Drug Delivery Systems Market.
The key players operating the global novel drug delivery systems market involves Abbott Laboratories, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Roche Holding AG, and Sanofi SA.